RPL39

mutation — cross-omics
Cross-omicsMUTATION → IMMUNEPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RPL39 mutation is significantly associated with the immune_cell of many other genes, with 2 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible RPL39-associated genes across cancer lineages are Endothelial cells and Erythrocytes. Each is linked with RPL39 in more than 1 cancer types. Because this analysis shows association rather than direction, both RPL39-to-partner and partner-to-RPL39 results are reported.

Each partner links to its own Q-omics profile.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (RPL39→partner) and Y-score (partner→RPL39) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
UCECEndothelial cells →-0.038-3.416.045.00531
UCECErythrocytes →+0.026+2.321.033.03611
Each partner links to its Q-omics profile. Showing the 2 strongest of 2 associations by consensus.

Exploration